IBDEI0T6 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14404,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,14404,1,5,0)
 ;;=5^Cellulitis Of Orbit
 ;;^UTILITY(U,$J,358.3,14404,2)
 ;;=^259068
 ;;^UTILITY(U,$J,358.3,14405,0)
 ;;=681.10^^90^859^11
 ;;^UTILITY(U,$J,358.3,14405,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14405,1,4,0)
 ;;=4^681.10
 ;;^UTILITY(U,$J,358.3,14405,1,5,0)
 ;;=5^Cellulitis Of Toe
 ;;^UTILITY(U,$J,358.3,14405,2)
 ;;=^271885
 ;;^UTILITY(U,$J,358.3,14406,0)
 ;;=682.2^^90^859^12
 ;;^UTILITY(U,$J,358.3,14406,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14406,1,4,0)
 ;;=4^682.2
 ;;^UTILITY(U,$J,358.3,14406,1,5,0)
 ;;=5^Cellulitis Of Trunk
 ;;^UTILITY(U,$J,358.3,14406,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,14407,0)
 ;;=070.1^^90^859^26
 ;;^UTILITY(U,$J,358.3,14407,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14407,1,4,0)
 ;;=4^070.1
 ;;^UTILITY(U,$J,358.3,14407,1,5,0)
 ;;=5^Hepatitis A 
 ;;^UTILITY(U,$J,358.3,14407,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,14408,0)
 ;;=070.30^^90^859^27
 ;;^UTILITY(U,$J,358.3,14408,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14408,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,14408,1,5,0)
 ;;=5^Hepatitis B, Acute
 ;;^UTILITY(U,$J,358.3,14408,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,14409,0)
 ;;=070.32^^90^859^28
 ;;^UTILITY(U,$J,358.3,14409,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14409,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,14409,1,5,0)
 ;;=5^Hepatitis B, Chronic
 ;;^UTILITY(U,$J,358.3,14409,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,14410,0)
 ;;=070.51^^90^859^29
 ;;^UTILITY(U,$J,358.3,14410,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14410,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,14410,1,5,0)
 ;;=5^Hepatitis C, Acute
 ;;^UTILITY(U,$J,358.3,14410,2)
 ;;=^266632
 ;;^UTILITY(U,$J,358.3,14411,0)
 ;;=070.54^^90^859^30
 ;;^UTILITY(U,$J,358.3,14411,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14411,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,14411,1,5,0)
 ;;=5^Hepatitis C, Chronic
 ;;^UTILITY(U,$J,358.3,14411,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,14412,0)
 ;;=571.41^^90^859^32
 ;;^UTILITY(U,$J,358.3,14412,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14412,1,4,0)
 ;;=4^571.41
 ;;^UTILITY(U,$J,358.3,14412,1,5,0)
 ;;=5^Hepatitis, Chronic Persist
 ;;^UTILITY(U,$J,358.3,14412,2)
 ;;=^259093
 ;;^UTILITY(U,$J,358.3,14413,0)
 ;;=571.1^^90^859^33
 ;;^UTILITY(U,$J,358.3,14413,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14413,1,4,0)
 ;;=4^571.1
 ;;^UTILITY(U,$J,358.3,14413,1,5,0)
 ;;=5^Hepatitis, ETOH acute
 ;;^UTILITY(U,$J,358.3,14413,2)
 ;;=^2597
 ;;^UTILITY(U,$J,358.3,14414,0)
 ;;=070.59^^90^859^34
 ;;^UTILITY(U,$J,358.3,14414,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14414,1,4,0)
 ;;=4^070.59
 ;;^UTILITY(U,$J,358.3,14414,1,5,0)
 ;;=5^Hepatitis, Other Viral
 ;;^UTILITY(U,$J,358.3,14414,2)
 ;;=Hepatitis, Other Viral^266631
 ;;^UTILITY(U,$J,358.3,14415,0)
 ;;=V08.^^90^859^24
 ;;^UTILITY(U,$J,358.3,14415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14415,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,14415,1,5,0)
 ;;=5^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,14415,2)
 ;;=HIV + Status (Asymptomatic)^303392
 ;;^UTILITY(U,$J,358.3,14416,0)
 ;;=042.^^90^859^25
 ;;^UTILITY(U,$J,358.3,14416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14416,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,14416,1,5,0)
 ;;=5^HIV Disease (symptomatic)
 ;;^UTILITY(U,$J,358.3,14416,2)
 ;;=HIV Disease (symptomatic)^266500
 ;;^UTILITY(U,$J,358.3,14417,0)
 ;;=464.00^^90^859^2
 ;;^UTILITY(U,$J,358.3,14417,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14417,1,4,0)
 ;;=4^464.00
 ;;^UTILITY(U,$J,358.3,14417,1,5,0)
 ;;=5^Acute Laryngitis
